Schedule 13G ownership disclosure

AMBRX BIOPHARMA INC

Security class unavailable · CUSIP: 02290A102

Event date: 2023-02-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
13.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-23-006676
Form type
SC 13G/A
Filer
Ambrx Biopharma Cayman, Inc.
CIK
CIK 1836056
Filed
Mar 03, 2023
Reporting period
Feb 23, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub